Intelligence · Clinical Pipeline
Lxo Ireland Designated Pipeline
All ClinicalTrials.gov programs at Lxo Ireland Designated — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Lxo Ireland Designated has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
Low intensity laser for oral mucositis
Lxo Ireland Designated Activity Company
Oral Mucositis
1 trial -
Pre-dilation side branch
Lxo Ireland Designated Activity Company
Coronary Angiography
1 trial -
Roflumilast alternated days
Lxo Ireland Designated Activity Company
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Subcutaneous glargine insulin
Lxo Ireland Designated Activity Company
Diabetes Mellitus
1 trial
Frequently asked questions
How many pipeline programs does Lxo Ireland Designated have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs